Severfield (SFR) Competitors GBX 52.20 +0.20 (+0.38%) (As of 12/20/2024 11:48 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendHeadlinesInsider Trades SFR vs. TRX, NAK, EGI, IMG, EDG, MTA, NGR, RRS, NG, and WPMShould you be buying Severfield stock or one of its competitors? The main competitors of Severfield include Tissue Regenix Group (TRX), Nakama Group plc (NAK.L) (NAK), (EGI.L) (EGI), 532753 (IMG.L) (IMG), 651814 (EDG.L) (EDG), ArcelorMittal (MTA), Nature Group (NGR), Randgold Resources (RRS), National Grid (NG), and Wheaton Precious Metals (WPM). These companies are all part of the "precious metals" industry. Severfield vs. Tissue Regenix Group Nakama Group plc (NAK.L) (EGI.L) 532753 (IMG.L) 651814 (EDG.L) ArcelorMittal Nature Group Randgold Resources National Grid Wheaton Precious Metals Severfield (LON:SFR) and Tissue Regenix Group (LON:TRX) are both small-cap industrials companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, earnings, analyst recommendations, dividends, profitability, media sentiment, institutional ownership and valuation. Is SFR or TRX more profitable? Severfield has a net margin of 3.43% compared to Tissue Regenix Group's net margin of -3.46%. Severfield's return on equity of 7.25% beat Tissue Regenix Group's return on equity.Company Net Margins Return on Equity Return on Assets Severfield3.43% 7.25% 4.69% Tissue Regenix Group -3.46%-3.31%0.50% Does the media prefer SFR or TRX? In the previous week, Severfield had 2 more articles in the media than Tissue Regenix Group. MarketBeat recorded 3 mentions for Severfield and 1 mentions for Tissue Regenix Group. Severfield's average media sentiment score of 0.55 beat Tissue Regenix Group's score of 0.00 indicating that Severfield is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Severfield 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tissue Regenix Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings & valuation, SFR or TRX? Severfield has higher revenue and earnings than Tissue Regenix Group. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Severfield, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSeverfield£463.46M0.34£15.90M£0.051,044.00Tissue Regenix Group£31.80M1.30-£1.10M-£0.01-5,812.50 Which has more risk and volatility, SFR or TRX? Severfield has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. Comparatively, Tissue Regenix Group has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Do insiders and institutionals hold more shares of SFR or TRX? 66.9% of Severfield shares are held by institutional investors. Comparatively, 37.0% of Tissue Regenix Group shares are held by institutional investors. 4.4% of Severfield shares are held by insiders. Comparatively, 47.3% of Tissue Regenix Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community favor SFR or TRX? Severfield received 64 more outperform votes than Tissue Regenix Group when rated by MarketBeat users. Likewise, 76.09% of users gave Severfield an outperform vote while only 69.53% of users gave Tissue Regenix Group an outperform vote. CompanyUnderperformOutperformSeverfieldOutperform Votes22676.09% Underperform Votes7123.91% Tissue Regenix GroupOutperform Votes16269.53% Underperform Votes7130.47% SummarySeverfield beats Tissue Regenix Group on 12 of the 15 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Severfield News Delivered to You Automatically Sign up to receive the latest news and ratings for SFR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SFR vs. The Competition Export to ExcelMetricSeverfieldEngineering & Construction IndustryIndustrials SectorLON ExchangeMarket Cap£156.82M£2.01B£4.52B£1.85BDividend Yield4.64%3.58%4.06%10.60%P/E Ratio1,044.00368.71370.351,786.40Price / Sales0.3435.60448.55377,495.10Price / Cash16.9413.3429.3728.01Price / Book0.742.333.322.91Net Income£15.90M£75.80M£196.12M£155.90M7 Day Performance-4.74%-1.53%-0.97%-1.91%1 Month Performance-40.00%-1.54%-0.01%17.62%1 Year Performance-16.35%67.99%25.96%29.01% Severfield Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SFRSeverfieldN/AGBX 52.20+0.4%N/A-16.1%£156.82M£463.46M1,044.001,900News CoverageGap UpTRXTissue Regenix GroupN/AGBX 59.50+2.6%N/A+7.6%£42.38M£31.80M-5,800.00120News CoverageGap UpNAKNakama Group plc (NAK.L)N/AN/AN/A+0.0%£1.44M£8.09M-6.1353Gap DownHigh Trading VolumeEGI(EGI.L)N/AN/AN/AN/A£0.00N/A0.006Gap DownHigh Trading VolumeIMG532753 (IMG.L)N/AN/AN/AN/A£0.00N/A0.005,360High Trading VolumeEDG651814 (EDG.L)N/AN/AN/AN/A£0.00N/A0.002,610MTAArcelorMittalN/AN/AN/AN/A£0.00N/A0.009News CoverageHigh Trading VolumeNGRNature GroupN/AN/AN/AN/A£0.00N/A0.0010Gap UpRRSRandgold ResourcesN/AGBX 6,546+7,701,076.5%N/AN/A£0.00N/A0.0021,300News CoverageGap UpNGNational Grid2.0689 of 5 starsGBX 944.40+0.4%GBX 1,181.25+25.1%-12.6%£46.18B£19.85B1,717.0910High Trading VolumeWPMWheaton Precious Metals0.654 of 5 starsGBX 4,790.51-0.4%GBX 5,200+8.5%+15.0%£21.73B£1.13B5,024.3842News CoveragePositive News Related Companies and Tools Related Companies Tissue Regenix Group Competitors Nakama Group plc (NAK.L) Competitors (EGI.L) Competitors 532753 (IMG.L) Competitors 651814 (EDG.L) Competitors ArcelorMittal Competitors Nature Group Competitors Randgold Resources Competitors National Grid Competitors Wheaton Precious Metals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:SFR) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Severfield plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Severfield With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
